Advanced Diagnostic Solutions for Precision Medicine
NABL-accredited laboratory offering 93 specialized diagnostic tests across 11 clinical specialties. From prenatal genetics to infectious disease detection, we provide accurate, timely results that guide critical healthcare decisions.
Rapid molecular detection panels for specific genetic disorders using targeted PCR, MLPA, and next-generation sequencing methodologies.
Complete mitochondrial DNA (mtDNA) sequencing analyzing all 37 genes for diagnosis of mitochondrial disorders. Detects point mutations, deletions, and heteroplasmy levels in mitochondrial genome causing oxidative phosphorylation defects.
Multiplex ligation-dependent probe amplification (MLPA) detecting exon-level deletions and duplications in disease-associated genes. Used for Duchenne/Becker muscular dystrophy (DMD), spinal muscular atrophy, and other conditions where copy number variants are pathogenic.
Molecular diagnosis of spinal muscular atrophy determining SMN1 gene copy number (deletions/duplications) and SMN2 copy number for prognostic information. Essential for newborn screening, carrier testing, and prenatal diagnosis.
Targeted mutation analysis of common CFTR gene mutations causing cystic fibrosis. Detects ~30-40 most prevalent mutations accounting for 80-90% of CF alleles in various populations. Used for carrier screening and diagnostic confirmation.
Sequential testing for myeloproliferative neoplasms analyzing JAK2 V617F mutation, then reflex to CALR exon 9 and MPL W515 mutations if JAK2 negative. Diagnoses polycythemia vera, essential thrombocythemia, and primary myelofibrosis.